News | August 24, 2011

Health Quest Radiation Oncology Selects RayStation

August 24, 2011 – RaySearch Laboratories has received an order for its RayStation treatment planning system from Health Quest Systems Inc., headquartered in LaGrange, N.Y.

Health Quest’s radiation oncology enterprise comprises the departments of four community locations that have been serving regional patients in New York’s Mid-Hudson Valley since 1887: Dyson Cancer Center at Vassar Brothers Medical Center in Poughkeepsie; Ulster Radiation Oncology Center in Kingston, a joint venture with Benedictine Hospital; Fishkill Radiation Oncology in Fishkill; and Wagner Cancer Pavilion at Putnam Hospital Center in Carmel.

Health Quest will use RayStation as its treatment planning system for advanced treatments, such as intensity-modulated radiotherapy (IMRT), and will be serving the four treatment centers with a central patient database and thin client access throughout the departments. Health Quest will systematically replace its current treatment planning system with RayStation for all external beam treatment planning over a phased transition period.

The order also includes multi-criteria optimization, which is an advanced product enabling a more efficient treatment planning process. This highly intuitive tool lets the clinician evaluate the impact of changing different treatment priorities in real-time, which has a large potential to speed up the time-consuming treatment planning optimization process.

Health Quest Systems Senior Medical Physicist George Sherouse said, “I have been privileged in my career to be present at the launch of several game-changing innovations in radiation oncology treatment planning. As the first totally new commercial platform in some time, designed and built by an established industry leading software house, RayStation promises to be another game-changer. The rate at which RaySearch is able to deliver innovations in clinical software is remarkable to me. I’m thrilled to have the opportunity to lead an early adopter team at Health Quest.”

For more information: www.raysearchlabs.com

 

 

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init